Growth Metrics

HeartSciences (HSCS) Long-Term Debt Repayments (2025)

HeartSciences posted quarterly Long-Term Debt Repayments of $350000.0 for Q4 2025, up 250.0% on a QoQ basis from $100000.0 in Q3 2025.

HeartSciences (HSCS) has 1 years of Long-Term Debt Repayments data on file, last reported at $350000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 HeartSciences 4.56 Mn 1.16 Mn - -

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 350,000.00
Oct 31, 2025 350,000.00
Jul 31, 2025 100,000.00
Jul 31, 2025 100,000.00